Gelex

Commission Implementing Decision (EU) 2021/1161 of 13 July 2021 amending Decision 2011/891/EU and Implementing Decisions (EU) 2017/1211, (EU) 2017/1212, (EU) 2017/2449, (EU) 2019/2085 and (EU) 2019/2086 as regards the authorisation holder and its representative in the Union for the placing on the market of products containing, consisting of, or produced from certain genetically modified organisms (notified under document C(2021) 5148) (Text with EEA relevance) (Only the Dutch text is authentic)

In forceVersion 2021-07-13from 2021-07-14
Grade B

mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.

Ask Gelex about this law

Address https://gelex.eu/eli/EU/decision/2021/1161@2021-07-13/en

Contents
  1. Preamble
    1. Article 1 Amendments to Decision 2011/891/EU
  3. Article 1 Amendments to Decision 2011/891/EU
  4. (1)
    1. Article 6 Authorisation holder
    1. Article 1 Amendments to Decision 2011/891/EU
  6. (2)
    1. Article 8 Addressee
    1. Article 1 Amendments to Decision 2011/891/EU
    2. Article 2 Amendments to Implementing Decision (EU) 2017/1211
  8. Article 2 Amendments to Implementing Decision (EU) 2017/1211
  9. (1)
    1. Article 6 Authorisation holder
    1. Article 2 Amendments to Implementing Decision (EU) 2017/1211
  11. (2)
    1. Article 8 Addressee
    1. Article 2 Amendments to Implementing Decision (EU) 2017/1211
    2. Article 3 Amendments to Implementing Decision (EU) 2017/1212
  13. Article 3 Amendments to Implementing Decision (EU) 2017/1212
  14. (1)
    1. Article 6 Authorisation holder
    1. Article 3 Amendments to Implementing Decision (EU) 2017/1212
  16. (2)
    1. Article 8 Addressee
    1. Article 3 Amendments to Implementing Decision (EU) 2017/1212
    2. Article 4 Amendments to Implementing Decision (EU) 2017/2449
  18. Article 4 Amendments to Implementing Decision (EU) 2017/2449
  19. (1)
    1. Article 7 Authorisation holder
    1. Article 4 Amendments to Implementing Decision (EU) 2017/2449
  21. (2)
    1. Article 9 Addressee
    1. Article 4 Amendments to Implementing Decision (EU) 2017/2449
    2. Article 5 Amendments to Implementing Decision (EU) 2019/2085
  23. Article 5 Amendments to Implementing Decision (EU) 2019/2085
  24. (1)
    1. Article 7 Authorisation holder
    1. Article 5 Amendments to Implementing Decision (EU) 2019/2085
  26. (2)
    1. Article 9 Addressee
    1. Article 5 Amendments to Implementing Decision (EU) 2019/2085
    2. Article 6 Amendments to Implementing Decision (EU) 2019/2086
  28. Article 6 Amendments to Implementing Decision (EU) 2019/2086
  29. (1)
    1. Article 7 Authorisation holder
    1. Article 6 Amendments to Implementing Decision (EU) 2019/2086
  31. (2)
    1. Article 9 Addressee
    1. Article 6 Amendments to Implementing Decision (EU) 2019/2086
    2. Article 7 Addressee

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified food and feed, and in particular to Article 9(2) and Article 21(2) thereof,

Whereas:

(1) Dow AgroSciences Distribution SAS based in France is the representative in the Union of Mycogen Seeds LLC, based in the United States, concerning the authorisations for the placing on the market of products containing, consisting of, or produced from genetically modified organisms granted by Commission Decision 2011/891/EU and Commission Implementing Decision (EU) 2017/1211.

(2) Dow AgroSciences Distribution SAS, based in France, is the representative in the Union of Dow AgroSciences LLC, based in the United States, as regards the authorisations for the placing on the market of products containing, consisting of, or produced from certain genetically modified organisms, granted by Commission Implementing Decisions (EU) 2017/1212, (EU) 2017/2449, (EU) 2019/2085 and (EU) 2019/2086.

(3) By the letter of 22 March 2021, Corteva Agriscience LLC, based in the United States informed the Commission that Dow AgroSciences LLC changed the name to Corteva Agriscience LLC as of 1 January 2021.

(4) In a joint letter of 22 March 2021, Corteva Agriscience LLC and Mycogen LLC requested the transfer of the authorisations held by Mycogen LLC to Corteva Agriscience LLC.

(5) By letter dated 22 March 2021, Corteva Agriscience LLC informed the Commission that its representative in the Union was Corteva Agriscience Belgium BV, based in Belgium, as of 22 March 2021.

(6) The requested changes are purely administrative in nature and therefore do not entail a new assessment of the products concerned.

(7) Decision 2011/891/EU and Implementing Decisions (EU) 2017/1211, (EU) 2017/1212, (EU) 2017/2449, (EU) 2019/2085 and (EU) 2019/2086 should therefore be amended accordingly.

(8) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS DECISION:

Article 1 Amendments to Decision 2011/891/EU

Decision 2011/891/EU is amended as follows:

(1) Article 6 is replaced by the following:

Article 1 Amendments to Decision 2011/891/EU

(1)

Article 6 Authorisation holder

The authorisation holder shall be Corteva Agriscience LLC, United States, represented in the Union by Corteva Agriscience Belgium BV.

Article 1 Amendments to Decision 2011/891/EU

(2) Article 8 is replaced by the following:

Article 1 Amendments to Decision 2011/891/EU

(2)

Article 8 Addressee

This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana 46268-1054, United States, represented in the Union by Corteva Agriscience Belgium BV, Bedrijvenlaan 9, 2800 Mechelen, Belgium.

Article 1 Amendments to Decision 2011/891/EU

(3) in the Annex, point (a) is replaced by the following:

(a) Applicant and authorisation holder Name: Corteva Agriscience LLC Address: 9330 Zionsville Road Indianapolis, Indiana 46268-1054, United States, represented in the Union by Corteva Agriscience Belgium BV, Bedrijvenlaan 9, 2800 Mechelen, Belgium.

Article 2 Amendments to Implementing Decision (EU) 2017/1211

Implementing Decision (EU) 2017/1211 is amended as follows:

(1) Article 6 is replaced by the following:

Article 2 Amendments to Implementing Decision (EU) 2017/1211

(1)

Article 6 Authorisation holder

The authorisation holder shall be Corteva Agriscience LLC, United States, represented in the Union by Corteva Agriscience Belgium BV.

Article 2 Amendments to Implementing Decision (EU) 2017/1211

(2) Article 8 is replaced by the following:

Article 2 Amendments to Implementing Decision (EU) 2017/1211

(2)

Article 8 Addressee

This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana 46268-1054, United States, represented in the Union by Corteva Agriscience Belgium BV, Bedrijvenlaan 9, 2800 Mechelen, Belgium.

Article 2 Amendments to Implementing Decision (EU) 2017/1211

(3) in the Annex, point (a) is replaced by the following:

(a) Applicant and authorisation holder Name: Corteva Agriscience LLC Address: 9330 Zionsville Road Indianapolis, Indiana 46268-1054, United States, represented in the Union by Corteva Agriscience Belgium BV, Bedrijvenlaan 9, 2800 Mechelen, Belgium.

Article 3 Amendments to Implementing Decision (EU) 2017/1212

Implementing Decision (EU) 2017/1212 is amended as follows:

(1) Article 6 is replaced by the following:

Article 3 Amendments to Implementing Decision (EU) 2017/1212

(1)

Article 6 Authorisation holder

The authorisation holder shall be Corteva Agriscience LLC, United States, represented in the Union by Corteva Agriscience Belgium BV.

Article 3 Amendments to Implementing Decision (EU) 2017/1212

(2) Article 8 is replaced by the following:

Article 3 Amendments to Implementing Decision (EU) 2017/1212

(2)

Article 8 Addressee

This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana 46268-1054, United States, represented in the Union by Corteva Agriscience Belgium BV, Bedrijvenlaan 9, 2800 Mechelen, Belgium.

Article 3 Amendments to Implementing Decision (EU) 2017/1212

(3) in the Annex, point (a) is replaced by the following:

(a) Authorisation holder Name: Corteva Agriscience LLC Address: 9330 Zionsville Road Indianapolis, Indiana 46268-1054, United States, represented in the Union by Corteva Agriscience Belgium BV, Bedrijvenlaan 9, 2800 Mechelen, Belgium.

Article 4 Amendments to Implementing Decision (EU) 2017/2449

Implementing Decision (EU) 2017/2449 is amended as follows:

(1) Article 7 is replaced by the following:

Article 4 Amendments to Implementing Decision (EU) 2017/2449

(1)

Article 7 Authorisation holder

The authorisation holder shall be Corteva Agriscience LLC, United States, represented in the Union by Corteva Agriscience Belgium BV.

Article 4 Amendments to Implementing Decision (EU) 2017/2449

(2) Article 9 is replaced by the following:

Article 4 Amendments to Implementing Decision (EU) 2017/2449

(2)

Article 9 Addressee

This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana 46268-1054, United States, represented in the Union by Corteva Agriscience Belgium BV, Bedrijvenlaan 9, 2800 Mechelen, Belgium.

Article 4 Amendments to Implementing Decision (EU) 2017/2449

(3) in the Annex, point (a) is replaced by the following:

(a) Authorisation holder Name: Corteva Agriscience LLC Address: 9330 Zionsville Road Indianapolis, Indiana 46268-1054, United States, represented in the Union by Corteva Agriscience Belgium BV, Bedrijvenlaan 9, 2800 Mechelen, Belgium.

Article 5 Amendments to Implementing Decision (EU) 2019/2085

Implementing Decision (EU) 2019/2085 is amended as follows:

(1) Article 7 is replaced by the following:

Article 5 Amendments to Implementing Decision (EU) 2019/2085

(1)

Article 7 Authorisation holder

The authorisation holder shall be Corteva Agriscience LLC, United States, represented in the Union by Corteva Agriscience Belgium BV.

Article 5 Amendments to Implementing Decision (EU) 2019/2085

(2) Article 9 is replaced by the following:

Article 5 Amendments to Implementing Decision (EU) 2019/2085

(2)

Article 9 Addressee

This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana 46268-1054, United States, represented in the Union by Corteva Agriscience Belgium BV, Bedrijvenlaan 9, 2800 Mechelen, Belgium.

Article 5 Amendments to Implementing Decision (EU) 2019/2085

(3) in the Annex, point (a) is replaced by the following:

(a) Applicant and authorisation holder Name: Corteva Agriscience LLC Address: 9330 Zionsville Road Indianapolis, Indiana 46268-1054, United States, represented in the Union by Corteva Agriscience Belgium BV, Bedrijvenlaan 9, 2800 Mechelen, Belgium.

Article 6 Amendments to Implementing Decision (EU) 2019/2086

Implementing Decision (EU) 2019/2086 is amended as follows:

(1) Article 7 is replaced by the following:

Article 6 Amendments to Implementing Decision (EU) 2019/2086

(1)

Article 7 Authorisation holder

The authorisation holder shall be Corteva Agriscience LLC, United States, represented in the Union by Corteva Agriscience Belgium BV.

Article 6 Amendments to Implementing Decision (EU) 2019/2086

(2) Article 9 is replaced by the following:

Article 6 Amendments to Implementing Decision (EU) 2019/2086

(2)

Article 9 Addressee

This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana 46268-1054, United States, represented in the Union by Corteva Agriscience Belgium BV, Bedrijvenlaan 9, 2800 Mechelen, Belgium.

Article 6 Amendments to Implementing Decision (EU) 2019/2086

(3) in the Annex, point (a) is replaced by the following:

(a) Applicant and authorisation holder Name: Corteva Agriscience LLC Address: 9330 Zionsville Road Indianapolis, Indiana 46268-1054, United States, represented in the Union by Corteva Agriscience Belgium BV, Bedrijvenlaan 9, 2800 Mechelen, Belgium.

Article 7 Addressee

This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road Indianapolis, Indiana 46268-1054, United States, represented in the Union by Corteva Agriscience Belgium BV, Bedrijvenlaan 9, 2800 Mechelen, Belgium.

Done at Brussels, 13 July 2021. For the Commission Stella Kyriakides Member of the Commission

Versions

  1. 2021-07-13